| 000 | 01737 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250516080734.0 | ||
| 264 | 0 | _c20130402 | |
| 008 | 201304s 0 0 eng d | ||
| 022 | _a0172-6390 | ||
| 024 | 7 |
_a10.5754/hge10621 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTreska, Vladislav | |
| 245 | 0 | 0 |
_aPrognostic value of the number and volume of liver tumours on portal vein embolization outcomes. _h[electronic resource] |
| 260 |
_bHepato-gastroenterology _c |
||
| 300 |
_a448-52 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aCone-Beam Computed Tomography |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 |
_aEmbolization, Therapeutic _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHepatectomy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver Neoplasms _xblood supply |
| 650 | 0 | 4 | _aLiver Regeneration |
| 650 | 0 | 4 | _aLogistic Models |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoadjuvant Therapy _xadverse effects |
| 650 | 0 | 4 |
_aNeoplasms, Multiple Primary _xblood supply |
| 650 | 0 | 4 | _aOdds Ratio |
| 650 | 0 | 4 | _aPortal Vein |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aROC Curve |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aTumor Burden |
| 700 | 1 | _aSkalicky, Tomas | |
| 700 | 1 | _aLiska, Vaclav | |
| 700 | 1 | _aSutnar, Alan | |
| 700 | 1 | _aFerda, Jiri | |
| 700 | 1 | _aMirka, Hynek | |
| 700 | 1 | _aSlauf, Frantisek | |
| 700 | 1 | _aKreuzberg, Boris | |
| 700 | 1 | _aFichtl, Jakub | |
| 773 | 0 |
_tHepato-gastroenterology _gvol. 59 _gno. 114 _gp. 448-52 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.5754/hge10621 _zAvailable from publisher's website |
| 999 |
_c21563139 _d21563139 |
||